Related references
Note: Only part of the references are listed.Is there additional value attached to health gains at the end of life? A revisit
Dorte Gyrd-Hansen
HEALTH ECONOMICS (2018)
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
David Cameron et al.
GLOBAL HEALTH ACTION (2018)
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
Aris Angelis et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
Re-Thinking The Different Perspectives That can be Used When Eliciting Preferences in Health'
Aki Tsuchiya et al.
HEALTH ECONOMICS (2017)
New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations
Takeru Shiroiwa et al.
HEALTH POLICY (2017)
Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan
Takeru Shiroiwa et al.
VALUE IN HEALTH (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making
Takeru Shiroiwa et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)
The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review
Y. Schuller et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness
Mikael Svensson et al.
PHARMACOECONOMICS (2015)
Systematic overview of cost-effectiveness thresholds in ten countries across four continents
Ruth Schwarzer et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2015)
COMPARING WTP VALUES OF DIFFERENT TYPES OF QALY GAIN ELICITED FROM THE GENERAL PUBLIC
Mark Pennington et al.
HEALTH ECONOMICS (2015)
A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
Khachapon Nimdet et al.
PLOS ONE (2015)
Valuing QALYs at the end of life
Jose-Luis Pinto-Prades et al.
SOCIAL SCIENCE & MEDICINE (2014)
Japan: Universal Health Care at 50 Years 2 Japanese universal health coverage: evolution, achievements, and challenges
Naoki Ikegami et al.
LANCET (2011)
INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS?
Takeru Shiroiwa et al.
HEALTH ECONOMICS (2010)
Health technology assessment in England: assessment and appraisal
Tom Walley
MEDICAL JOURNAL OF AUSTRALIA (2007)
National Institute for Clinical Excellence and its value judgments
MD Rawlins et al.
BRITISH MEDICAL JOURNAL (2004)
An inquiry into the different perspectives that can be used when eliciting preferences in health
P Dolan et al.
HEALTH ECONOMICS (2003)
National Institute for Clinical Excellence (NICE): Is economic appraisal working?
A Towse et al.
PHARMACOECONOMICS (2002)
Share Paper
